We were founded in 1996 with a mission to improving people’s health by developing safe and high-quality branded first generic medicines at affordable prices. This was at a time when a number of local and international pharmaceutical products were present in the Jordanian local market but lacked alternative non- branded products especially in the Central Nervous System (CNS) medicines.
We were the first in Jordan to manufacture quality branded first generic medicines for the Central Nervous System (CNS). We started production in 2001 at our plant in Na’ur, Jordan with CNS, Cardiovascular, and Anti-Infective medicines.
Within three years, we established our presence within the Jordan pharmaceutical industry through our dedication to quality, innovation and excellence.
More than 20 years later, we remain committed to improving people’s health, enhancing our medicines, and extending our reach to the communities in which we operate.
Shandong Kexing Bioproducts Co.,Ltd. is a biotech pharmaceutical enterprise.Mainly engaged in the R&D,manufacturing and marketing of biological products including Recombinant human erythropoietin injection (rh-EPO ), Recombinant human granulocyte colony-stimulating factor injection(rhG-CSF/Filgrastim) and live clostridium butyricum and bifidobacterium preparation. The APIs of the products are also available
SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.
Our commitment is to continue to offer essential drugs meeting Public Health needs.
Lunan Pharmaceutical Group Co. Ltd. manufactures medicines. The Company researches, develops, produces, and sells traditional Chinese medicines, chemical medicines, and bio-pharmaceutical medicinal products. Lunan Pharmaceutical Group also operates pharmaceutical engineering technology research center and postdoctoral scientific research workstation.
Since the foundation in 1975, PharmaKing has been devoted to researching new medicine, with the strong belief that there is nothing more precious than life and hope for disease-free world. As a result, in 1990, for the first time in Korea, we developed the hepatitis medicine Nissel Tab. and opened a new era of liver disease treatment. In 1998, the company patented a new medicine for liver disease treatmentand launched Pennel, which passed the phase 3 trial that is difficult for pharmaceutical companies,establishing itself as a R&D-oriented biotechnology company.
CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093.HK) is a leading pharmaceutical group in China. The Company has been listed on the Main Board of the Hong Kong Stock Exchange since 1994 and became a constituent stock of the Hang Sang Index in 2018 (the 1st pharmaceutical stock to be included for 50 years). CSPC is currently also a constituent stock of the "Hang Seng Composite Index", "Hang Seng Healthcare Index", "Hang Seng Mainland Healthcare Index", "Hang Seng Stock Connect Hong Kong Index" and "Hang Seng China (Hong Kong-listed) 100 Index" and "Hang Seng China Enterprises Index"